• <noscript id="yywya"><kbd id="yywya"></kbd></noscript>
  • 發布時間:2019-08-07 17:00 原文鏈接: PurificationofrecombinantsBRFM166L

    Induction of BRF in bacteria and purification on Ni-NTA agarose

    Transform BRF plasmid into strain BL21 DE3 (pLysS) or JM25 (DE3 containing the Arg tRNA over expression plasmid under lac iQ control Kanomycin resistant)

    Inoculate 6 ml of a saturated overnight culture of the transformed bacteria into 2X 1 Liter of YT Amp (50 ug/ml) (and Kan (30 ug/ml) if using strain JM25) (adding 1-2 drops of antifoam A before autoclaving the YT will decrease the foam in the culture during growth). Incubate at 30 deg till the culture reaches OD600 ~ 0.6. Remove a small 1 ml sample for an uninduced control, and incubate this small sample on the tube roller for an additional 4 hrs.

    Induce the large culture with 0.4 mM IPTG (4 ml of 0.1 M IPTG per 1000 ml) and grow at 30 deg. for four hours. Take a small sample of the induced and uninduced cultures and save for analysis of whole cell protein by SDS PAGE.

    Harvest cells by centrifugation (4-6g). Resuspend the cell pellet in 160 ml Lysis buffer. The cells can be frozen at this point in liquid N2 and stored at -70 deg.

    It is usually a good idea to analyze the BRF induction by analysis of total cell protein before proceeding.

    Thaw the lysed cells at room temp. Sonicate 2 times for 30 sec. each time using the large sonicator tip. Alternatively, the cells can be run once through the microfluidizer.

    Centrifuge the crude lysate in the GSA rotor for 30 min at 10K RPM.

    During the above GSA spin, prepare the Ni-NTA resin for BRF binding. Transfer 12 mls of Ni-NTA affinity bead slurry (50% beads; 6 ml of beads total) to a 50ml conical tube and centrifuge 3min at 3K RPM in the GPR centrifuge.

    Equilibrate the beads 2X with Lysis buffer by resuspension and centrifugation.

    Add the equilibrated beads to the clarified extract and place on a room temp. shaker platform for 45 min.

    Centrifuge the bead-extract mix in the GSA rotor for 5 min at 5K RPM and carefully remove the supernatant (the pellet of beads will not be very firm so it seems best to remove as much supernatant as possible with a pipette and don’t worry if not all the sup. can be removed). Save this supernatant in case there is a problem with the BRF binding.

    Resuspend the beads with a small amount of Lysis buffer and transfer to a 50 ml conical tube. Use extra lysis buffer to wash the GSA bottle to remove all beads. Spin in the GRP rotor and carefully remove sup. by dumping (the pellets will not be very firm so it is OK if not all the sup. can be removed. Wash the beads 5X with ~35 ml Wash Buffer.

    After the final wash, transfer the beads to 15ml conical tubes with Wash Buffer. Centrifuge the beads and try to remove all of the supernatant with a Pasteur pipette leaving the beads semi-dry.

    Add a volume of Elution Buffer which is equal to the volume of the beads (6 ml) and place on a roller at RT for 20 min. Centrifuge the beads in the GPR and remove the supernatant and save; this is the first protein elution. Repeat the elution and freeze samples. Analyze recovery by SDS PAGE and/or protein assay. Typical recovery is 2 to 6 mg BRF protein.


    Lysis/Binding buffer, pH 8.0 (150 ml)

    30mM Tris 8.00.54 g Tris
    300mM NaCl2.63 g NaCl
    6.0M Gu-HCl86 g Guanidine-HCl
    10mM Imidazole0.1 g Imidazole

     

    Wash Buffer, pH8.0 (200 ml)

    30 mM Tris 8.00.73 g Tris
    300mM NaCl3.5 g NaCl
    8.0M Urea96.2 g Urea
    10mM Imidazole0.136 g Imidazole

    H2O to 200 ml final

    Elution Buffer, pH 8.0 (50 ml)

    20mM Tris 8.00.12 g Tris
    300mM NaCl0.87 g NaCl
    8.0M Urea24 g Urea
    100mM Imidazole0.33 g Imidazole

    H2O to 50 ml final

     


    Renaturation of BRF protein

    Thaw Ni-NTA purified samples. Dilute the sample to a concentration of 0.25 to 0.5mg/ml in the elution buffer. To the BRF sample, add 10% Brij58 detergent to a final concentration of 0.1% Brij, add DTT to 5 mM final concentration, add ZnS04 to a concentration of 20 micromolar, and add all protease inhibitors to 1X concentration. For each dialysis step, use a buffer to sample ratio of 40:1. Dialyze 4 times for four hours each time into decreasing amounts of Urea: 4M, then 2M, then 0.75M, and then 0M Urea. Spin renatured protein in the SS34 rotor for 10 min at 10K rpm. If a large pellet is detected, analyze the samples by SDS PAGE before proceeding with the purification to confirm that the renatured BRF is soluble.


    BRF Renaturation Buffer (1.5 liters)

    10% glycerol150 ml glycerol
    20 mM HEPES 7.97.14 g HEPES
    150 mM KCl16.8 g KCl
    5 mM MgCl27.5 ml 1 M MgCl2
    1 mM EDTA8 ml 0.25 M EDTA
    20 micromolar ZnSO40.3 ml 0.1 M ZnSO4
    0.1% Brij 581.5 g Brij 58

    H2O to a final volume of 1.5 liters

    Add protease inhibitors and DTT to 5 mM just prior to dialysis.

    Protease inhibitors for BRF renaturation:

    0.1 M PMSF (100x)

    16 mg/ml Ethanol

    Store at -20 degrees

    Benzamidine (100X)

    31 mg/ml H2O.

    Store frozen at -20 degrees

    Leupeptin (500X)

    0.15 mg/ml Ethanol.

    Store at -70 degrees for less than 6 months

    Pepstatin (200X)

    0.28 mg/ml methanol

    Store at -20 degrees.

    Chymostatin (2,500X)

    5mg/ml DMSO

    Store frozen at -20 degrees


    Purification of BRF using SOURCE 15Q Ion Exchange Chromatography

    Thaw the renatured BRF (in 150 mM KCl) and dilute with buffer B +0 KCl to a final KCl concentration of 50 mM. Filter the diluted sample through a 0.22 micron syringe filter before loading.

    Load the filtered sample to a 0.5 ml SOURCE 15 Q column equilibrated in B + 50 mM KCl at a flow rate of 0.5 ml/min.

    Wash the column with 6 column volumes of B + 50 mM KCl.

    Elute with a 50 column volume gradient from 50 mM KCl to 550 mM KCl. Collect 0.5 ml fractions. BRF elutes in 2-3 fractions after about 1/3 of the gradient has completed at a conductivity of about 12 mS/cm-16mS/cm on the ATKA instrument. Expect 0.5- 1 mg of highly purified BRF protein from 10ml of renatured and diluted BRF.

    Wash the column with 5 column volumes of B + 1.0 M KCl and 5 column volumes of 20% ETOH to clean. If the column pressure exceeds pressure limits and the ETOH cleaning does not cure the problem, follow the more extensive cleaning procedure recommended by Pharmacia.


    Buffers for Ion Exchange Chromatography

    B + 0 NaCl (500 ml)

    30 mM Tris 8.01.82 g Tris
    1 mM EDTA2 ml 0.25 M EDTA
    10% glycerol50 ml glycerol

    H2O to a final volume of 500 ml

    B + 1 M NaCl (500 ml)

    30 mM Tris 8.01.82 g Tris
    1 mM EDTA2 ml 0.25 M EDTA
    10% glycerol50 ml glycerol
    1 M KCl37.3 g KCl

    H2O to a final volume of 500 ml

    Add DTT to 1 mM and protease inhibitors to 1x before use. Filter buffers through 0.22 micron filter before using on FPLC.

     

    Pefablock (Boehringer) (1000x)

    100 mg/ml H2O stock store at -20 deg.

    Leupeptin (500X)

    0.15 mg/ml Ethanol.

    相關文章

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    發力癌癥分子病理診斷,無錫臻和全資收購TissueofOrigin?

    2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和ZL轉讓協議,全資收購這款唯一獲FDA......

    這3個雜志撤回中國學者249篇文章,包含上交、中山等名校

    2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    島津推出NexeraPrepPurificationLC可節省空間并多樣品處理

    分析測試百科網訊近日,島津公司推出了NexeraPrep系列制備型純化液相色譜儀(LC)。“制備工作”是從樣品中分離和純化特定物質的過程。該過程對于在制藥工業中的藥物發現期間提取目標化合物和雜質以及提......

    llumina宣布推出新型基因分型芯片|支持AllofUs研究計劃

    2018年12月6日,來自圣迭戈的消息——Illumina公司(納斯達克股票代碼:ILMN)今天宣布推出新型高密度基因分型芯片Infinium?GlobalDiversityArray。這款芯片設計源......

    SDSPAGE異常電泳現象及分析SDSPAGEHallofShame

    SDS-PAGE異常電泳現象及分析SDS-PAGEHallofShame.pdf  很不錯的東東~~推薦下~......

    BovineGMCSF(YeastderivedRecombinantProtein)解決方案

    活性氮(RNS)是巨噬細胞在稱為氧化爆發的過程中響應病原體而產生的一組殺菌分子。一氧化氮(NO)是由精氨酸通過誘導的一氧化氮合酶(iNOS)產生的RNS的成員。刺激后巨噬細胞產生iNOS的活性和NO是......

    牛GMCSF重組蛋白/BovineGMCSFRecombinantProtein

    粒細胞-巨噬細胞集落刺激因子(granulocyte-macrophagecolony-stimulatingfactor,GM-CSF)主要由T細胞和巨噬細胞產生,能夠誘導粒細胞前體和巨噬細胞前體細......

    牛粒細胞巨噬細胞集落刺激因子/BovineGMCSF重組蛋白中英文說明書

    艾美捷牛粒細胞-巨噬細胞集落刺激因子/BovineGM-CSF重組蛋白中文說明書:目錄編號(規格):RP0871B-005(5μg)RP0871B-025(25μg)RP0871B-100(100μg......

  • <noscript id="yywya"><kbd id="yywya"></kbd></noscript>
  • 东京热 下载